Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

In vivo imaging of bioluminescent Pseudomonas aeruginosa in an acute murine airway infection model.

Munder A, Wölbeling F, Klockgether J, Wiehlmann L, Tümmler B.

Pathog Dis. 2014 Oct;72(1):74-7. doi: 10.1111/2049-632X.12184. Epub 2014 Jun 30.

PMID:
24833236
2.

Fitness of isogenic colony morphology variants of Pseudomonas aeruginosa in murine airway infection.

Rakhimova E, Munder A, Wiehlmann L, Bredenbruch F, Tümmler B.

PLoS One. 2008 Feb 27;3(2):e1685. doi: 10.1371/journal.pone.0001685.

3.

Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.

Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B.

Am J Respir Crit Care Med. 2009 Jul 15;180(2):138-45. doi: 10.1164/rccm.200812-1943OC. Epub 2009 May 7.

PMID:
19423715
4.

Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection.

Bianconi I, Milani A, Cigana C, Paroni M, Levesque RC, Bertoni G, Bragonzi A.

PLoS Pathog. 2011 Feb 3;7(2):e1001270. doi: 10.1371/journal.ppat.1001270.

5.

A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection.

Carter ME, Fothergill JL, Walshaw MJ, Rajakumar K, Kadioglu A, Winstanley C.

J Infect Dis. 2010 Sep 15;202(6):935-42. doi: 10.1086/655781.

PMID:
20704484
6.

Assessing Pseudomonas aeruginosa virulence and the host response using murine models of acute and chronic lung infection.

Kukavica-Ibrulj I, Facchini M, Cigana C, Levesque RC, Bragonzi A.

Methods Mol Biol. 2014;1149:757-71. doi: 10.1007/978-1-4939-0473-0_58.

PMID:
24818948
7.

Key role of an ADP - ribose - dependent transcriptional regulator of NAD metabolism for fitness and virulence of Pseudomonas aeruginosa.

Okon E, Dethlefsen S, Pelnikevich A, Barneveld AV, Munder A, Tümmler B.

Int J Med Microbiol. 2017 Jan;307(1):83-94. doi: 10.1016/j.ijmm.2016.09.007. Epub 2016 Nov 5.

PMID:
27865623
8.

Assessing Pseudomonas virulence using mammalian models: acute infection model.

Munder A, Tümmler B.

Methods Mol Biol. 2014;1149:773-91. doi: 10.1007/978-1-4939-0473-0_59.

PMID:
24818949
9.

Multiple roles of Pseudomonas aeruginosa TBCF10839 PilY1 in motility, transport and infection.

Bohn YS, Brandes G, Rakhimova E, Horatzek S, Salunkhe P, Munder A, van Barneveld A, Jordan D, Bredenbruch F, Häussler S, Riedel K, Eberl L, Jensen PØ, Bjarnsholt T, Moser C, Hoiby N, Tümmler B, Wiehlmann L.

Mol Microbiol. 2009 Feb;71(3):730-47. doi: 10.1111/j.1365-2958.2008.06559.x. Epub 2008 Dec 1.

10.

How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.

Pier GB, Grout M, Zaidi TS, Goldberg JB.

Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 2):S175-82.

PMID:
8876538
11.

Requirement of the Pseudomonas aeruginosa CbrA sensor kinase for full virulence in a murine acute lung infection model.

Yeung AT, Janot L, Pena OM, Neidig A, Kukavica-Ibrulj I, Hilchie A, Levesque RC, Overhage J, Hancock RE.

Infect Immun. 2014 Mar;82(3):1256-67. doi: 10.1128/IAI.01527-13. Epub 2013 Dec 30.

12.

In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.

Araki N, Yanagihara K, Morinaga Y, Yamada K, Yamada Y, Kohno S, Kamihira S.

J Infect Chemother. 2011 Jun;17(3):318-21. doi: 10.1007/s10156-010-0166-1. Epub 2010 Oct 23.

PMID:
20972597
13.

Long term chronic Pseudomonas aeruginosa airway infection in mice.

Facchini M, De Fino I, Riva C, Bragonzi A.

J Vis Exp. 2014 Mar 17;(85). doi: 10.3791/51019.

14.

Role of Pseudomonas aeruginosa quorum-sensing systems in a mouse model of chronic respiratory infection.

Imamura Y, Yanagihara K, Tomono K, Ohno H, Higashiyama Y, Miyazaki Y, Hirakata Y, Mizuta Y, Kadota J, Tsukamoto K, Kohno S.

J Med Microbiol. 2005 Jun;54(Pt 6):515-8.

PMID:
15888457
15.

Direct continuous method for monitoring biofilm infection in a mouse model.

Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, Rubin M, Bellinger-Kawahara C, Parr Jr TR Jr, Contag PR.

Infect Immun. 2003 Feb;71(2):882-90.

16.

Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, Allen GB, Vasil ML, Leclair LW, Hogan DA.

Am J Respir Crit Care Med. 2011 Aug 1;184(3):345-54. doi: 10.1164/rccm.201103-0374OC. Epub 2011 May 11.

17.

Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.

Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, Pier GB.

J Immunol. 2001 Jun 15;166(12):7410-8.

18.

Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.

Alcalá-Franco B, Montanari S, Cigana C, Bertoni G, Oliver A, Bragonzi A.

J Antimicrob Chemother. 2012 Apr;67(4):962-9. doi: 10.1093/jac/dkr587. Epub 2012 Feb 1.

PMID:
22294647
19.

Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice.

de Vrankrijker AM, Wolfs TF, Ciofu O, Høiby N, van der Ent CK, Poulsen SS, Johansen HK.

J Med Virol. 2009 Dec;81(12):2096-103. doi: 10.1002/jmv.21623.

PMID:
19856469

Supplemental Content

Support Center